Literature DB >> 2523883

Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status.

M R Horsman1, P V Hansen, J Overgaard.   

Abstract

Nicotinamide induced radiosensitization of tumors has been suggested to be a consequence of a reduction in tumor hypoxia. We have investigated the possibility that nicotinamide may produce significant radiosensitization in a normal tissue in which the radiation response is also influenced by hypoxia. The normal tissue studied was testis and radiation damage was assessed by measuring survival of spermatogonial stem cells. The radiosensitizing action of nicotinamide in testis was compared to that observed in a C3H mammary carcinoma when assayed by both regrowth delay and local tumor control. Our results show that nicotinamide (1000 mg/kg; i.p.) enhanced radiation damage in both tissue types when the radiation was given up to at least 3 hr after drug injection. Enhancement ratios obtained when the drug and radiation were separated by a 1 hr time interval were between 1.1 to 1.2 for the testis and 1.0 to 1.5 for the tumor. The results suggest that nicotinamide will produce radiosensitization in testis, but the effect is small and less than that observed in tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523883     DOI: 10.1016/0360-3016(89)90297-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation.

Authors:  Lotte B Bertelsen; Yuan Yuan Shen; Thomas Nielsen; Hans Stødkilde-Jørgensen; G Kenneth Lloyd; Dietmar W Siemann; Michael R Horsman
Journal:  Int J Radiat Biol       Date:  2011-11       Impact factor: 2.694

2.  Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.

Authors:  M R Horsman; D J Chaplin
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

3.  Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.

Authors:  D J Honess; N M Bleehen
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.